Understanding the Body's Response to Red Blood Cells
Immune Response to RBC Antigens
This work explores why some people's immune systems mistakenly attack their own red blood cells, leading to a condition called autoimmune hemolytic anemia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11184295 on NIH RePORTER |
What this research studies
Our bodies usually know how to protect red blood cells, which are vital for carrying oxygen. However, for some individuals, this protection breaks down, causing their immune system to create antibodies that destroy these essential cells. This can lead to serious health issues like anemia and fatigue. We are working to uncover the exact reasons why this immune system error happens, which could help us find better ways to prevent and treat this condition. By understanding how the body's tolerance to its own red blood cells is lost, we hope to develop more effective strategies for patients.
Who could benefit from this research
Good fit: This foundational research is relevant to patients diagnosed with autoimmune hemolytic anemia or those experiencing unexplained anemia due to red blood cell destruction.
Not a fit: Patients whose anemia is not related to an autoimmune response against their red blood cells may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of autoimmune hemolytic anemia, paving the way for new and more effective treatments for patients.
How similar studies have performed: While the exact mechanisms of immune tolerance to red blood cells are still being uncovered, other studies have shown success in understanding immune system breakdowns in various autoimmune diseases.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Hudson, Krystalyn E — Columbia University Health Sciences
- Study coordinator: Hudson, Krystalyn E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.